Acadia Pharmaceuticals Inc. · NASDAQ:ACAD
Thompson Elizabeth H.Z. sold 16,558 Acadia Pharmaceuticals Inc. shares (Form 4)
Traded Jul 29 to Jul 30, 2026 · Filed Jul 31, 2026
From Jul 29 to Jul 30, 2026, Thompson Elizabeth H.Z. (EVP, Head of Research & Dev) sold 16,558 Acadia Pharmaceuticals Inc. shares at an average US$26.13 for US$433K, leaving 18,994 shares. Filed Jul 31, 2026 (Form 4).
- Sold
- 16,558 shares
- Price
- US$26.13 average (US$26.13 to US$26.17)
- Value
- US$433K
- Holding after
- 18,994 shares
- Trading plan
- No
- Role
- EVP, Head of Research & Dev
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 29, 2026 | Common Stock | Option exercise | 32,272 | 35,552 | Direct | |
| Jul 30, 2026 | Common Stock | Sale | 16,508 | US$26.13 | 19,044 | Direct |
| Jul 30, 2026 | Common Stock | Sale | 50 | US$26.17 | 18,994 | Direct |
Source
Related
- Acadia Pharmaceuticals Inc.
- Thompson Elizabeth H.Z.
- Acadia Pharmaceuticals Inc. shareholders
- Form 4 · Schneyer Mark C. · Aug 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Kihara James · Jun 29, 2026
- Form 4 · Baker Brothers Life Sciences LP · Jun 2, 2026
- Form 4 · Harrigan Edmund · Jun 1, 2026